{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:33:40Z","timestamp":1792514020188,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1053\/j.gastro.2014.03.048","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T14:14:15Z","timestamp":1396361655000},"page":"143-151.e5","source":"Crossref","is-referenced-by-count":296,"title":["Association of Nucleos(t)ide Analogue Therapy With Reduced Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B\u2014A Nationwide Cohort Study"],"prefix":"10.1053","volume":"147","author":[{"given":"Chun-Ying","family":"Wu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Town","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hsiu J.","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Wei","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teng-Yu","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shen-Yung","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuhui","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaw-Ching","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2014.03.048_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3322\/caac.20107","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"key":"10.1053\/j.gastro.2014.03.048_bib2","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1053\/j.gastro.2007.04.061","article-title":"Hepatocellular carcinoma: epidemiology and molecular carcinogenesis","volume":"132","author":"El-Serag","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.03.048_bib3","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N\u00a0Engl J Med"},{"key":"10.1053\/j.gastro.2014.03.048_bib4","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S1726-4901(09)70346-6","article-title":"Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors","volume":"70","author":"Liu","year":"2007","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1053\/j.gastro.2014.03.048_bib5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1093\/jnci\/djr430","article-title":"Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma","volume":"103","author":"Sherman","year":"2011","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1053\/j.gastro.2014.03.048_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S0140-6736(09)60207-5","article-title":"Hepatitis B virus infection","volume":"373","author":"Liaw","year":"2009","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2014.03.048_bib7","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1440-1746.2011.06695.x","article-title":"Natural history of chronic hepatitis B REVEALed","volume":"26","author":"Chen","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2014.03.048_bib8","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.295.1.65","article-title":"Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level","volume":"295","author":"Chen","year":"2006","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2014.03.048_bib9","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/j.jhep.2009.07.009","article-title":"Risk factors for early and late recurrence in hepatitis B-related hepatocellular carcinoma","volume":"51","author":"Wu","year":"2009","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2014.03.048_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jhep.2009.04.003","article-title":"Antiviral therapy of chronic hepatitis B: opportunities and challenges in Asia","volume":"51","author":"Liaw","year":"2009","journal-title":"J\u00a0Hepatol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2014.03.048_bib11","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1440-1746.2010.06545.x","article-title":"Treatment of chronic hepatitis B: evolution over two decades","volume":"26","author":"Yuen","year":"2011","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2014.03.048_bib12","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1056\/NEJMoa033364","article-title":"Lamivudine for patients with chronic hepatitis B and advanced liver disease","volume":"351","author":"Liaw","year":"2004","journal-title":"N\u00a0Engl J Med"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2014.03.048_bib13","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1478-3231.2010.02388.x","article-title":"Impact of hepatitis B therapy on the long-term outcome of liver disease","volume":"31","author":"Liaw","year":"2011","journal-title":"Liver Int"},{"key":"10.1053\/j.gastro.2014.03.048_bib14","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1002\/hep.23785","article-title":"Long-term entecavir therapy results in the reversal of fibrosis\/cirrhosis and continued histological improvement in patients with chronic hepatitis B","volume":"52","author":"Chang","year":"2010","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.03.048_bib15","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S0140-6736(12)61425-1","article-title":"Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study","volume":"381","author":"Marcellin","year":"2013","journal-title":"Lancet"},{"key":"10.1053\/j.gastro.2014.03.048_bib16","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/hep.25937","article-title":"Prevention of hepatitis B virus-related hepatocellular carcinoma with antiviral therapy","volume":"57","author":"Lai","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.03.048_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/hep.26317","article-title":"Does hepatitis B treatment reduce the incidence of hepatocellular carcinoma?","volume":"58","author":"Sherman","year":"2013","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.03.048_bib18","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1001\/2012.jama.11975","article-title":"Association between nucleos(t)ide analogues and risk of hepatitis B virus-related hepatocellula carcinoma recurrence following liver resection","volume":"308","author":"Wu","year":"2012","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2014.03.048_bib19","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1111\/j.1365-2036.2008.03816.x","article-title":"Meta-analysis: treatment of hepatitis B infection reduces risk of hepatocellular carcinoma","volume":"28","author":"Sung","year":"2008","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2014.03.048_bib20","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.jhep.2010.02.035","article-title":"Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: a systematic review","volume":"53","author":"Papatheodoridis","year":"2010","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2014.03.048_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2013-306409","article-title":"Patients with chronic hepatitis B treated with oral antiviral therapy retain a higher risk for HCC compared with patients with inactive stage disease","author":"Cho","year":"2014","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.03.048_bib22","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/jvh.12054","article-title":"Long-term outcome of hepatitis B virus-related chronic hepatitis under protracted nucleos(t)ide analogues","volume":"20","author":"Niro","year":"2013","journal-title":"J\u00a0Viral Hepatol"},{"key":"10.1053\/j.gastro.2014.03.048_bib23","doi-asserted-by":"crossref","first-page":"2952","DOI":"10.1200\/JCO.2009.26.0695","article-title":"Effective reduction of gastric cancer risk with regular use of nonsteroidal anti-inflammatory drugs in Helicobacter pylori-infected patients","volume":"28","author":"Wu","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.03.048_bib24","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1053\/j.gastro.2009.07.060","article-title":"Early Helicobacter pylori eradication decreases risk of gastric cancer in patients with peptic ulcer disease","volume":"137","author":"Wu","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.03.048_bib25","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1053\/j.gastro.2010.06.067","article-title":"Histamine 2-receptor antagonists are an alternative to proton pump inhibitor in patients receiving clopidogrel","volume":"139","author":"Wu","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.03.048_bib26","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/pds.2087","article-title":"Validation of the National Health Insurance Research Database with ischemic stroke cases in Taiwan","volume":"20","author":"Cheng","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1053\/j.gastro.2014.03.048_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1162\/003465302317331982","article-title":"Propensity score-matching methods for nonexperimental causal studies","volume":"84","author":"Dehejia","year":"2002","journal-title":"Rev Econ Stat"},{"key":"10.1053\/j.gastro.2014.03.048_bib28","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2307\/2530374","article-title":"The analysis of failure times in the presence of competing risks","volume":"34","author":"Prentice","year":"1978","journal-title":"Biometrics"},{"key":"10.1053\/j.gastro.2014.03.048_bib29","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1214\/aos\/1176350951","article-title":"A\u00a0class of K-sample tests for comparing the cumulative incidence of a competing risk","volume":"16","author":"Gray","year":"1988","journal-title":"Ann Stat"},{"key":"10.1053\/j.gastro.2014.03.048_bib30","doi-asserted-by":"crossref","first-page":"948","DOI":"10.2307\/2533848","article-title":"Assessing the sensitivity of regression results to unmeasured confounders in observational studies","volume":"54","author":"Lin","year":"1998","journal-title":"Biometrics"},{"key":"10.1053\/j.gastro.2014.03.048_bib31","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to an event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2014.03.048_bib32","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/gut.2010.221846","volume":"60","author":"Papatheodoridis","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.03.048_bib33","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.hepres.2005.02.006","article-title":"Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: a multicenter retrospective study of 2795 patients","volume":"32","author":"Matsumoto","year":"2005","journal-title":"Hepatol Res"},{"key":"10.1053\/j.gastro.2014.03.048_bib34","first-page":"664A","article-title":"The effect of lamivudine and adefovir dipivoxil on preventing hepatocellular carcinoma in hepatitis B virus-related liver cirrhosis","volume":"46","author":"Eun","year":"2007","journal-title":"Hepatology"},{"key":"10.1053\/j.gastro.2014.03.048_bib35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1136\/gutjnl-2011-301708","article-title":"Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in\u00a0vitro studies","volume":"62","author":"Chen","year":"2012","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.03.048_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1053\/j.gastro.2003.10.065","article-title":"Diabetes increases the\u00a0risk of chronic liver disease and hepatocellular carcinoma","volume":"126","author":"El-Serag","year":"2004","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2014.03.048_bib37","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1136\/gut.2004.052167","article-title":"Diabetes increases the risk of hepatocellular carcinoma in the United States: a population based case control study","volume":"54","author":"Davila","year":"2005","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2014.03.048_bib38","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1200\/JCO.2009.26.2675","article-title":"Clinical scoring system to predict hepatocellular carcinoma in chronic hepatitis B carriers","volume":"28","author":"Wong","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.03.048_bib39","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1200\/JCO.2009.27.4456","article-title":"Nomograms for risk of hepatocellular carcinoma in patients with chronic hepatitis B virus infection","volume":"28","author":"Yang","year":"2010","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1053\/j.gastro.2014.03.048_bib40","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S1470-2045(11)70077-8","article-title":"Risk estimation for hepatocellular carcinoma in chronic hepatitis B (REACH-B): development and validation of a predictive score","volume":"12","author":"Yang","year":"2011","journal-title":"Lancet Oncol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514004454?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508514004454?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T06:51:19Z","timestamp":1538722279000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508514004454"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S0016508514004454"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2014.03.048","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}